Biosensor's Novel Drug-Coated Stent First For U.S. Clinical Trial
This article was originally published in PharmAsia News
Executive Summary
Singapore's Biiosensors International said it has received U.S. FDA approval for a clinical trial of its drug-eluting stent without having to test the first-of-its-kind device on at least 100 patients.